Corticosteroid

WASHINGTON — Swallowed corticosteroid treatment did not impact growth velocity among children with eosinophilic esophagitis, according to a poster presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Nearly 40% of children with oligoarticular juvenile idiopathic arthritis treated with intra-articular corticosteroids required no additional therapy, according to data published in Arthritis Research & Therapy.

The prevalence of severe persistent asthma among patients with asthma significantly ranges across the United States, from 19.6% in New Mexico to 31.9% in Alaska, according to a study published in Annals of Allergy, Asthma & Immunology.

This year’s asthma research covered a broad variety of topics, such as the effect of the family dog’s fur on long-term outcomes, asthma care in prison, fast food restaurants and the Canadian wildfires.

Two new practice parameters from a joint task force published in Annals of Allergy, Asthma & Immunology provide evidence-based recommendations for the diagnosis and management of anaphylaxis and atopic dermatitis.

Intranasal corticosteroids did not impact COVID-19 mortality in patients with asthma, COPD or neither, but they did reduce the risk for all-cause mortality, according to study results published in Annals of Allergy, Asthma & Immunology.

Patients with interstitial lung disease and surfactant-related gene mutations showed progressive lung function decline and reduced survival that was comparable to that of other ILD groups, according to results published in CHEST.

The timing of corticosteroid exposure during pregnancy was not associated with any delays in neurodevelopmental milestones during the first 3 years of life, according to a study published in JAMA Network Open.

The timing of corticosteroid exposure during pregnancy was not associated with any delays in neurodevelopmental milestones during the first 3 years of life, according to a study published in JAMA Network Open.

HONOLULU — The risk for all-cause mortality was reduced among patients with community-acquired pneumonia who used hydrocortisone vs. other corticosteroids, according to a poster presented at the CHEST Annual Meeting.